Literature DB >> 24102827

Postural tachycardia syndrome following human papillomavirus vaccination.

S Blitshteyn1.   

Abstract

BACKGROUND AND
PURPOSE: Postural tachycardia syndrome (POTS) is a heterogeneous disorder of the autonomic nervous system that may have an autoimmune etiology.
METHODS: Six patients who developed new onset POTS 6 days to 2 months following human papillomavirus vaccination are reported.
RESULTS: Three patients also had neurocardiogenic syncope, and three patients were diagnosed with possible small fiber neuropathy. Symptoms in all patients improved over 3 years with pharmacotherapy and non-pharmacological measures but residual symptoms persisted. Molecular mimicry with formation of cross-reacting autoantibodies to the potential targets of the autonomic ganglia, neurons, cardiac proteins or vascular receptors is considered as a possible pathogenesis of new onset POTS after immunization.
CONCLUSION: Correct diagnosis of POTS and awareness that POTS may occur after vaccination in young women is essential for prompt and effective management of this condition.
© 2013 The Author(s) European Journal of Neurology © 2013 EFNS.

Entities:  

Keywords:  disorders of the autonomic nervous system; human papillomavirus vaccination; neuropathy; postural tachycardia syndrome; small fibers; vaccination

Mesh:

Substances:

Year:  2013        PMID: 24102827     DOI: 10.1111/ene.12272

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  23 in total

Review 1.  Fibromyalgia and small fiber neuropathy: the plot thickens!

Authors:  Manuel Martínez-Lavín
Journal:  Clin Rheumatol       Date:  2018-09-20       Impact factor: 2.980

Review 2.  Suspected adverse effects after human papillomavirus vaccination: a temporal relationship.

Authors:  Shu-Ichi Ikeda; Akiyo Hineno; Kazuki Ozawa; Tomomi Kinoshita
Journal:  Immunol Res       Date:  2018-12       Impact factor: 2.829

3.  Postural tachycardia syndrome (POTS) with anti-NMDA receptor antibodies after human papillomavirus vaccination.

Authors:  Svetlana Blitshteyn; Jill Brook
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

4.  Comment on: "Safety of Human Papillomavirus Vaccines: An Updated Review".

Authors:  Manuel Martínez-Lavín
Journal:  Drug Saf       Date:  2018-05       Impact factor: 5.606

Review 5.  Autonomic dysfunction and HPV immunization: an overview.

Authors:  Svetlana Blitshteyn; Louise Brinth; Jeanne E Hendrickson; Manuel Martinez-Lavin
Journal:  Immunol Res       Date:  2018-12       Impact factor: 2.829

Review 6.  Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction.

Authors:  Yahel Segal; Yehuda Shoenfeld
Journal:  Cell Mol Immunol       Date:  2018-03-05       Impact factor: 11.530

7.  HPV vaccination discourses and the construction of "at-risk" girls.

Authors:  Geneviève Rail; Luisa Molino; Caroline Fusco; Moss Edward Norman; LeAnne Petherick; Jessica Polzer; Fiona Moola; Mary Bryson
Journal:  Can J Public Health       Date:  2018-08-03

Review 8.  Human papillomavirus (HPV) vaccine and autonomic disorders: a position statement from the American Autonomic Society.

Authors:  Alexandru Barboi; Christopher H Gibbons; Felicia Axelrod; Eduardo E Benarroch; Italo Biaggioni; Mark W Chapleau; Gisela Chelimsky; Thomas Chelimsky; William P Cheshire; Victoria E Claydon; Roy Freeman; David S Goldstein; Michael J Joyner; Horacio Kaufmann; Phillip A Low; Lucy Norcliffe-Kaufmann; David Robertson; Cyndya A Shibao; Wolfgang Singer; Howard Snapper; Steven Vernino; Satish R Raj
Journal:  Clin Auton Res       Date:  2019-09-02       Impact factor: 4.435

Review 9.  Impact of 2-, 4- and 9-valent HPV vaccines on morbidity and mortality from cervical cancer.

Authors:  Rebecca Luckett; Sarah Feldman
Journal:  Hum Vaccin Immunother       Date:  2015-11-20       Impact factor: 3.452

10.  A Case of Postural Orthostatic Tachycardia Syndrome Secondary to the Messenger RNA COVID-19 Vaccine.

Authors:  Sujana Reddy; Satvik Reddy; Manish Arora
Journal:  Cureus       Date:  2021-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.